Potential cure for hepatitis B enters phase 1/2a clinical trial

Dr Marc Pellegrini (L), Dr Greg Ebert and colleagues have developed a new treatment for chronic hepatitis B infections that is entering clinical trials. Credit: Walter and Eliza Hall Institute
A new treatment developed by Walter and Eliza Hall Institute researchers to promote the cure of chronic hepatitis B virus (HBV) infection is now recruiting patients for a phase I/2a clinical trial.